Analysts expect that National Health Investors Inc (NYSE:NHI) will report sales of $72.38 million for the current fiscal quarter, Zacks reports. Two analysts have issued estimates for National Health Investors’ earnings. The lowest sales estimate is $72.31 million and the highest is $72.46 million. National Health Investors posted sales of $66.39 million in the same quarter last year, which would indicate a positive year-over-year growth rate of 9%. The company is scheduled to report its next quarterly earnings report on Tuesday, May 8th.
On average, analysts expect that National Health Investors will report full year sales of $72.38 million for the current financial year, with estimates ranging from $295.85 million to $298.47 million. For the next year, analysts forecast that the company will post sales of $319.99 million per share, with estimates ranging from $315.20 million to $324.79 million. Zacks Investment Research’s sales averages are a mean average based on a survey of research analysts that cover National Health Investors.
National Health Investors (NYSE:NHI) last announced its quarterly earnings results on Friday, February 16th. The real estate investment trust reported $0.90 earnings per share for the quarter, missing the consensus estimate of $1.33 by ($0.43). The company had revenue of $71.06 million for the quarter, compared to analysts’ expectations of $71.36 million. National Health Investors had a net margin of 57.19% and a return on equity of 12.20%.
National Health Investors (NYSE:NHI) opened at $68.48 on Wednesday. The company has a current ratio of 13.85, a quick ratio of 13.85 and a debt-to-equity ratio of 0.87. The firm has a market capitalization of $2,849.94, a P/E ratio of 17.64, a P/E/G ratio of 3.54 and a beta of 0.48. National Health Investors has a 12-month low of $62.71 and a 12-month high of $81.60.
The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, May 10th. Stockholders of record on Friday, March 30th will be given a $1.00 dividend. The ex-dividend date is Wednesday, March 28th. This is a boost from National Health Investors’s previous quarterly dividend of $0.95. This represents a $4.00 dividend on an annualized basis and a dividend yield of 5.84%. National Health Investors’s payout ratio is 98.19%.
In other news, CEO D. Eric Mendelsohn purchased 2,000 shares of the stock in a transaction dated Thursday, February 22nd. The shares were purchased at an average cost of $65.47 per share, with a total value of $130,940.00. Following the completion of the purchase, the chief executive officer now directly owns 10,580 shares of the company’s stock, valued at approximately $692,672.60. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, VP John L. Spaid purchased 500 shares of the stock in a transaction dated Thursday, February 22nd. The stock was purchased at an average cost of $64.95 per share, for a total transaction of $32,475.00. Following the completion of the purchase, the vice president now directly owns 971 shares of the company’s stock, valued at $63,066.45. The disclosure for this purchase can be found here. Insiders bought 2,812 shares of company stock valued at $183,910 over the last 90 days. Company insiders own 5.19% of the company’s stock.
Several large investors have recently modified their holdings of NHI. Zeke Capital Advisors LLC acquired a new stake in shares of National Health Investors in the fourth quarter worth approximately $226,000. Cubist Systematic Strategies LLC acquired a new stake in shares of National Health Investors in the third quarter worth approximately $237,000. Stephens Inc. AR acquired a new stake in shares of National Health Investors in the fourth quarter worth approximately $238,000. Dynamic Technology Lab Private Ltd acquired a new stake in shares of National Health Investors in the third quarter worth approximately $249,000. Finally, Xact Kapitalforvaltning AB acquired a new stake in shares of National Health Investors in the fourth quarter worth approximately $283,000. 71.89% of the stock is currently owned by hedge funds and other institutional investors.
COPYRIGHT VIOLATION WARNING: This piece of content was originally posted by American Banking News and is the property of of American Banking News. If you are accessing this piece of content on another site, it was illegally stolen and republished in violation of US & international copyright & trademark law. The legal version of this piece of content can be read at https://www.americanbankingnews.com/2018/03/14/72-38-million-in-sales-expected-for-national-health-investors-inc-nhi-this-quarter.html.
About National Health Investors
National Health Investors, Inc is a self-managed real estate investment trust (REIT) specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The Company is engaged in the business of owning and financing healthcare properties.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.